Health Care Commentary

Earlier this month, the Biden administration bought 10 million courses of Pfizer's new COVID-19 pill, Paxlovid. Thanks to the Food and Drug Administration, however, it may be months before anyone can take it, as the agency hasn't yet offered up a timetable for approving it. Its inaction will...

Earlier this month, President Biden tapped Dr. Robert Califf to lead the Food and Drug Administration. The agency had been operating without a Senate-approved commissioner for almost a year. In my last column, I detailed how the FDA's failures reviewing and approving tests for COVID-19 have prolonged the pandemic. This...

Late last month, the Biden administration announced a new initiative to lower the cost of at-home Covid-19 tests and make them more widely available. It's long past time. Throughout the pandemic, bureaucratic sclerosis has proven the American regulatory apparatus to be an impediment to fighting Covid-19—not to mention...

Last week, President Joe Biden unveiled a new social spending framework that omitted many of the healthcare provisions Democrats have been calling for. One provision that has survived is a massive and wasteful expansion of Obamacare . In March, Congress made federal tax credits available to those shopping for coverage...

Healthcare workers are exchanging scrubs and gloves for signs and megaphones. In what's been called "Striketober," frontline staff are walking out of hospitals, emergency rooms, and doctor's offices to insist on better pay, benefits, and hours. Earlier this month, Kaiser Permanente workers in California voted...